Epivir (Lamivudine)

Epivir
4.819 ratingsReviews
Generic:
Lamivudine
Indications:
HIV
Analogs:
Zeffix Emtriva Viread Vemlidy Baraclude Ziagen Truvada Descovy Dovato Triumeq Retrovir Combivir Epzicom Kivexa Hepsera
In stock: 16 packs
AdultsPregnancyAllergiesDiabetesBreastfeedingChildrenDriving

Dosages

Epivir 150 mg

Quantity Price per tablet You save Total price
30 A$4.51 - A$135.28
60 A$3.55 A$57.76 A$212.80
90 A$3.21 A$117.04 A$288.80
120 A$2.89 A$194.56 A$346.56
180 A$2.59 A$345.04 A$466.64
240 A$2.34 A$521.36 A$560.88

Manufacturers

Cipla LimitedGlaxoSmithKlineMylanratiopharmSandozTeva CanadaTeva Pharmaceutical IndustriesViiV Healthcare

Payment & Delivery

Package Example

Your order is carefully packed and ships within 24 hours. Here is what a typical package looks like.

Sized like a regular personal letter (approximately 24x11x0.7 cm), with no indication of what is inside.

Front View
Front View
Side View
Side View
Back View
Back View
Delivery Times
Delivery MethodEstimated delivery
Express Free for orders over A$456.00Estimated delivery to Australia: 4-7 days
Standard Free for orders over A$304.00Estimated delivery to Australia: 14-21 days
EMSAustralia Post
Payment Methods
VisaMastercardBitcoin, USDTApple PayGoogle PayEftposAfterpayZippayKlarnaPayPal

Discount Coupons

  • Australia Day - 26 January 2026 10% AUSDAY10
  • Labour Day - 2 March 2026 6% LABOUR6
  • ANZAC Day - 25 April 2026 8% ANZAC8
  • King's Birthday - 8 June 2026 7% KING7
  • Boxing Day - 26 December 2026 12% BOXING12

Brand Names

Also known as (by country):
CountryBrand Names
Australia
Lamivudine Sandoz

FAQ

Lamivudine 150 mg tablets are prescription-only medicines when bought through Australian pharmacies. Our store policy allows you to order this product without a prescription and have it sent by mail; this ordering policy is separate from its Australian prescription classification.

Contact the clinician managing your HIV treatment promptly to review the full regimen. Do not stop lamivudine or change the dose on your own, as interrupting antiretroviral treatment can affect viral control and may have other consequences.

Epivir 150 mg film-coated tablets containing lamivudine are registered prescription medicines in the Australian Register of Therapeutic Goods. The regulatory status of the particular generic product supplied cannot be confirmed in advance unless its manufacturer and package details are identified on the received pack.

Check the outer carton and blister or bottle label for "lamivudine", "150 mg", and "tablets". Also compare the dosage form, manufacturer name, batch number, expiry date and tablet imprint, if present, with the package information before taking the medicine.

Keep the medicine in its packaging and check the carton, seal, blisters or bottle, and tablets for damage, moisture, discolouration or other changes. Lamivudine tablets should be stored at 25°C, with permitted excursions from 15°C to 30°C.

This product is available as oral lamivudine tablets in a strength of 150 mg.

Epivir contains lamivudine, an antiviral medicine used with other antiretroviral medicines to treat HIV infection. Lamivudine also has activity against hepatitis B virus, but this 150 mg tablet product should be used only for the indication and regimen selected by the treating clinician.

Take the tablets by mouth, with or without food, at the times prescribed. For HIV treatment, lamivudine is used with other antiretroviral medicines; a standard adult regimen may be 150 mg twice daily or 300 mg once daily, but the appropriate regimen depends on the complete HIV treatment plan and kidney function.

Commonly reported effects include headache, nausea, tiredness, malaise, diarrhoea, cough and nasal symptoms. Seek urgent medical attention for signs of a serious allergic reaction, severe abdominal pain with persistent nausea or vomiting, unusual weakness, shortness of breath, or yellowing of the skin or eyes.

Tell the prescriber and pharmacist about all medicines, including over-the-counter products and supplements. Some medicines can affect lamivudine levels or add to treatment risks, including trimethoprim-containing medicines, bupropion, ribavirin, ganciclovir and valganciclovir; people with reduced kidney function need particular review.

Description

Note: Images in the description are provided for informational purposes and may differ from the actual appearance of the product. Please refer to the product name, strength, active ingredients, and dosage form.

Epivir 150 mg contains lamivudine (also known as "3TC"), a nucleoside reverse transcriptase inhibitor (NRTI) used with other antiretroviral medicines to treat HIV-1 infection.

Epivir (Lamivudine) 150 mg

How it works

Inside cells, lamivudine is converted into an active triphosphate form that inhibits HIV reverse transcriptase and blocks viral DNA synthesis. It helps reduce viral replication when taken as part of a complete antiretroviral regimen.

Can Epivir (lamivudine) prevent HIV?

Epivir is mainly used to treat people living with HIV and is not used on its own for pre-exposure prophylaxis (PrEP). For prevention, clinical guidelines usually recommend dedicated PrEP options, such as tenofovir/emtricitabine or long-acting cabotegravir, depending on eligibility and local guidance.

For PrEP or post-exposure prophylaxis (PEP) options, speak with an Australian clinician to choose the most suitable option.

Usual dosing (HIV-1)

  • Adults and adolescents: total daily dose 300 mg, taken as 150 mg twice daily or 300 mg once daily, as prescribed.
  • Can be taken with or without food.
  • Dose adjustment may be needed in renal impairment.

Abacavir plus lamivudine (ABC/3TC)

Abacavir + lamivudine (ABC/3TC) is a widely used backbone combination for HIV treatment. In some countries, it is available as a single fixed-dose tablet (for example, Epzicom or Kivexa) and is taken together with at least one other antiretroviral medicine.

Before starting abacavir-containing regimens, clinicians typically consider human leukocyte antigen B*5701 (HLA-B*5701) screening because of the risk of serious hypersensitivity reactions.

Important information

  • Epivir is taken with other antiretroviral medicines (not on its own for HIV treatment).
  • If you have HIV and hepatitis B virus (HBV), stopping lamivudine may cause a severe HBV flare-up. Do not stop treatment without medical advice.
  • Seek urgent medical help if you have symptoms that suggest lactic acidosis or severe liver problems.

This information is for general reference only and does not replace professional medical advice in Australia.

Epivir 150 mg tablets
Medically reviewed by
Brian Holtry
Brian Holtry
MD, infectious diseases specialist and medical writer
Updated 11 August 2026

Customer questions

Asked by Connor S, Logan City, Australia

I'm in Logan City and my parcel was left outside on a very hot afternoon. What should I check before I take the lamivudine tablets?

Answered by Support team

Keep the tablets in their original packaging and inspect the carton, seal, blister or bottle, and tablets for heat damage, moisture, discolouration or breakage. The labelled storage condition is 25°C, with permitted excursions from 15°C to 30°C; as we do not know the temperature or duration of exposure, do not use tablets that appear compromised until the discrepancy is checked.

Asked by Lachlan, Toowoomba, Australia

I live in Toowoomba. Can I enter my postcode before paying to see whether Epivir can be delivered to my address?

Answered by Support team

Yes. Enter your Toowoomba postcode at checkout to check the delivery options available for your address before completing the order.

Asked by Chloe, Coffs Harbour, Australia

I'm starting lamivudine and drive for work. Is it alright to drive after taking my first tablet?

Answered by Support team
Medical reviewed by Donna Brettler

Lamivudine does not have a specific sedating effect, but dizziness, headache, fatigue or malaise can occur. See how you feel before driving or operating machinery, and avoid driving if you are affected.

Product specifications

Active ingredientLamivudine
Drug classNucleoside reverse transcriptase inhibitor (NRTI)
Dosage formTablets
Available strengths150 mg
RouteOral
StorageStore at 25°C; excursions permitted to 15°C to 30°C.
ATC codeJ05AF05

Regulatory information

Approval statusLamivudine is fully registered and approved for human therapeutic use in Australia.
Prescription classificationLamivudine tablets are scheduled as a prescription-only medicine (Schedule 4) requiring a valid doctor's prescription.

More information

PBS search: lamivudineSearch Pharmaceutical Benefits Scheme listings and related information for lamivudine.pbs.gov.auTGA search: lamivudineSearch Australian therapeutic goods information and medicine records for lamivudine.tga.gov.auBetter Health Channel: lamivudineSearch Victorian public health information for content related to lamivudine.betterhealth.vic.gov.auDrugs.com: lamivudineReference information on lamivudine, including interactions, side effects and dosage forms.drugs.com

Other HIV medications